| | |||||||
| Ebola | |||||||
| NEWS | |||||||
| US hospitals prepare for COVID-19 amid uncertainty When Ebola reached US shores in 2014, healthcare workers and experts were kicking themselves for not being ready for a major infectious disease ...
| |||||||
| Why Boston Properties (BXP) is a Great Dividend Stock Right Now Merck (NYSE: MRK) announced on Friday that four African countries had approved the use of the company's Ebola vaccine, Ervebo. The Democratic ...
| |||||||
Coronavirus more infectious but less deadly than SARS and Ebola As the world continues to struggle to contain the spread of the deadly coronavirus, concerns continue to mount about what the long-term effects will be ...
| |||||||
| Ebola epidemic persists, WHO reveals NEW YORK: The World Health Organization (WHO) announced Wednesday (Thursday in Manila) that the Ebola outbreak which started in August ...
| |||||||
| Kraft Heinz Is Still a Mess "The approval of the Ebola vaccine by these countries is another milestone in the fight against this unforgiving disease. Africa has rallied to cement ...
| |||||||
| World in better preparedness for COVID-19 than a week ago: WHO head "I would like to urge the whole world to recommit to getting to zero Ebola cases. But it is also vitally important that resources and attention focus on ...
| |||||||
| Bill Gates warns that coronavirus impact could be 'very, very dramatic,' outlines long-term solutions That's in contrast earlier challenges such as Ebola, which were more dangerous to health workers attempting to treat people who were sick.
| |||||||
| Here's how to avoid getting sick on a cruise When passengers booked their vacations on the ill-fated Diamond Princess, they were likely looking forward to hanging out in a hot tub, not a hot zone ...
| |||||||
| WEB | |||||||
| Structural Basis for a Convergent Immune Response against Ebola Virus Ebola virus disease is a severe health problem in. Africa. Vaccines that display the Zaire ebolavirus glycoprotein spike complex are a prime ...
| |||||||
| Merck's Ebola Vaccine Approved for Use in Four African Countries Merck (NYSE: MRK) announced on Friday that four African countries had approved the use of the company's Ebola vaccine, Ervebo. The Democratic ...
| |||||||
| Genomic surveillance elucidates ebola virus origin and transmission during the 2014 outbreak Origin and transmission of Ebola virus outbreak. S. K. et ... (2014) via sequencing 99 Ebola virus genomes isolated from 78 patients (Gire et al. 2014).
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar